ArticleInflammatory bowel diseases2025

GLP-1 Receptor Agonists Confer No Increased Rates of IBD Exacerbation Among Patients With IBD.

Irving Levine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.